Filing Flows

Filing Flows › Comparisons › JANX vs ETST

Janux Therapeutics vs Earth Science Tech: JANX and ETST compared

Janux Therapeutics is the larger company: $9.3M of revenue in its latest quarter (Q3 2026) against $9.0M for Earth Science Tech (Q1 FY27). Earth Science Tech is growing faster (+3% against -7% a year earlier). Earth Science Tech is more profitable, with an operating margin of 10.6% against -336.5%.

Janux Therapeutics vs Earth Science Tech, latest quarterJanux Therapeutics vs Earth Science Tech, latest quarterJanux Therapeutics (JANX)Earth Science Tech (ETST)Revenue$9.3M$9.0MRevenue growth, Y/Y-7%+3%Operating margin-336.5%10.6%Net margin-232.2%7.9%

Where the money goes: JANX and ETST

Janux Therapeutics (JANX) · Q3 2026

Janux Therapeutics, Q3 2026: revenue $9.3M (-7% year over year), operating margin -336.5%, net loss $21.6M, operating cash flow −$25.2M. The chart follows the revenue to costs, profit and cash.

Earth Science Tech (ETST) · Q1 FY27

Earth Science Tech, Q1 FY27: revenue $9.0M (+3% year over year), operating margin 10.6%, net earnings $716K, operating cash flow $707K. The chart follows the revenue to costs, profit and cash.

Earth Science Tech revenue by segment, Q1 FY27Earth Science Tech revenue by segment, Q1 FY27Sale of Pharmaceutical Products a…$9.0MOther Revenue$31K
Janux Therapeutics (JANX)Earth Science Tech (ETST)
Latest quarterQ3 2026Q1 FY27
Revenue$9.3M$9.0M
Revenue growth, Y/Y-7%+3%
Gross margin—69.5%
Operating margin-336.5%10.6%
Net earnings−$21.6M$716K
Net margin-232.2%7.9%
Operating cash flow−$25.2M$707K
Free cash flow—$666K
Market value$1.2B—
Analysts’ mean target$32.53—

Where the revenue comes from

Earth Science Tech

Questions

Which is bigger, Janux Therapeutics or Earth Science Tech?

Janux Therapeutics is the larger company: $9.3M of revenue in its latest quarter (Q3 2026) against $9.0M for Earth Science Tech (Q1 FY27).

Is Janux Therapeutics or Earth Science Tech growing faster?

Earth Science Tech is growing faster (+3% against -7% a year earlier).

Which is more profitable, Janux Therapeutics or Earth Science Tech?

Earth Science Tech is more profitable, with an operating margin of 10.6% against -336.5%.

More: Janux Therapeutics earnings · how Janux Therapeutics makes money · Earth Science Tech earnings · how Earth Science Tech makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 7, 2026). Fiscal quarters can end on different dates. Not investment advice.